122 articles in GLP-1 & Metabolic · page 5 of 11

GLP-1 & Metabolic··6 min read

GLP-1S Explained: What the Product Code Denotes and the Evidence Behind It

GLP-1S is a vendor product code, not a molecule. What it denotes, the semaglutide science it points at, and why a grey vial is not the FDA drug.

Read →
GLP-1 & Metabolic··6 min read

GLP-2T Explained: The Dual-Agonist Product Code and the Evidence

GLP-2T is a vendor code for a tirzepatide-class dual agonist. The drug-class science is strong; the vial in your hand is unverified. The honest split.

Read →
GLP-1 & Metabolic··6 min read

GLP-3R Explained: The Triple-Agonist Product Code and the Evidence

GLP-3R is a vendor product code for a retatrutide-class triple agonist. The science is real and phase 2; the grey-market vial is not the drug.

Read →
GLP-1 & Metabolic··6 min read

Are GLP-1s Safe Long-Term?

GLP-1 drugs have over a decade of diabetes use and a shorter obesity record. What the multi-year data shows, and what it still cannot answer.

Read →
GLP-1 & Metabolic··5 min read

Cagrilintide: The Amylin Analog, Explained

Cagrilintide mimics the pancreatic hormone amylin. Paired with semaglutide as CagriSema it is Novo's next obesity bet — but not yet approved.

Read →
GLP-1 & Metabolic··5 min read

GLP-1s and Constipation: Managing the Other GI Effect

Nausea gets the headlines, but constipation is one of the most common GLP-1 side effects. Why it happens, and what helps.

Read →
GLP-1 & Metabolic··7 min read

GLP-1s in Pregnancy and Before Conception

GLP-1 drugs are not recommended in pregnancy, and labels call for stopping weeks to months before conceiving. What's known, and what isn't.

Read →
GLP-1 & Metabolic··5 min read

"Ozempic Face": Facial Aging and Rapid Fat Loss

Ozempic face is what happens to facial volume during any rapid weight loss, not a pharmacological side effect. The mechanism, and the options.

Read →
GLP-1 & Metabolic··8 min read

Ozempic vs Mounjaro: Which and For Whom

Semaglutide and tirzepatide both drive weight loss, but they hit different receptors and rest on different evidence. How to think about the choice.

Read →
GLP-1 & Metabolic··5 min read

Retatrutide vs Tirzepatide: Triple vs Dual Agonist

Tirzepatide hits two receptors and is approved. Retatrutide adds a third and posted bigger early numbers — but it is still investigational.

Read →
GLP-1 & Metabolic··5 min read

Stopping a GLP-1 Before Surgery: The Anesthesia Guidance

GLP-1 drugs slow stomach emptying, and that can matter under anesthesia even after a normal fast. Here's what anesthesiologists are actually recommending.

Read →
GLP-1 & Metabolic··5 min read

What Is Ozempic? A Plain-Language Explainer

Ozempic is a weekly injectable diabetes medicine that became a household name. What it is, how it works, and how it differs from Wegovy.

Read →